ClinicalTrials HQ

An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

Recruiting · NCT07665437 · Registry updated 2026-09-28
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HSBacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorderRecruitingPhase 32026-09-28NCT07665437

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Novartis Pharmaceuticals432

18 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Apex Clinical Research Center LLCMayfield HeightsUnited States3
Cameron DermatologyNew YorkUnited States3
Center for Clinical Studies-LeeWebsterUnited States2
Clinical Research Ctr of CarolinasCharlestonUnited States2
Clinical Trials Research InstituteThousand OaksUnited States5
Ctr for Dermatology Clinical ResFremontUnited States4
Dundee DermatologyWest DundeeUnited States7
Endeavor HealthGlenviewUnited States6
Floridian Research InstituteMiamiUnited States4
Icahn School Of Med At Mount SinaiNew YorkUnited States3
Johnson DermatologyFort SmithUnited States11
Olive View UCLA Medical CenterSylmarUnited States4
OnSite Clinical Solutions LLCHuntersvilleUnited States2
Optima Research BoardmanBoardmanUnited States4
Skin Specialists PCOmahaUnited States7
Southern IN Clinical TrialsNew AlbanyUnited States3
University of South FloridaTampaUnited States73
USC Keck School of MedicineLos AngelesUnited States8